Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Gastric Cancer

  Free Subscription

Articles published in Int J Cancer

Retrieve available abstracts of 79 articles:
HTML format

Single Articles

    May 2021
  1. HOFHEINZ RD, Hegewisch-Becker S, Kunzmann V, Thuss-Patience P, et al
    Trastuzumab in combination with 5-fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) as perioperative treatment for patients with HER2-positive locally advanced esophagogastric adenocarcinoma: A phase II trial of the AIO Gastric Cancer Study G
    Int J Cancer. 2021 May 21. doi: 10.1002/ijc.33696.
    PubMed     Abstract available

  2. COLLATUZZO G, Pelucchi C, Negri E, Lopez-Carrillo L, et al
    Exploring the interactions between Hp infection and other risk factors of gastric cancer: a pooled analysis in the Stomach cancer Pooling (StoP) Project.
    Int J Cancer. 2021 May 14. doi: 10.1002/ijc.33678.
    PubMed     Abstract available

    April 2021
  3. LIU C, Song K, Hu Q, Hu C, et al
    Having gastroesophageal cancer is associated with increased risk of severe COVID-19-related events in patients with digestive tract cancer: A multicenter, retrospective, cohort study.
    Int J Cancer. 2021;148:1789-1793.

    January 2021
  4. WATANABE Y, Oikawa R, Kodaka Y, Sato Y, et al
    Cancer-related genetic variants of Helicobacter pylori strains determined using gastric wash-based whole-genome analysis with single-molecule real-time technology.
    Int J Cancer. 2021;148:178-192.
    PubMed     Abstract available

    December 2020
  5. KATAGIRI R, Goto A, Shimazu T, Yamaji T, et al
    Dietary fiber intake and risk of gastric cancer: the Japan Public Health Center-based prospective study.
    Int J Cancer. 2020 Dec 21. doi: 10.1002/ijc.33450.
    PubMed     Abstract available

  6. CHOI J, Jia G, Wen W, Long J, et al
    Evaluating polygenic risk scores in assessing risk of nine solid and hematologic cancers in European descendants.
    Int J Cancer. 2020;147:3416-3423.
    PubMed     Abstract available

  7. EL KHADIR M, Boukhris Alaoui S, Benajah DA, Ibrahimi SA, et al
    VacA genotypes and cagA-EPIYA-C motifs of Helicobacter pylori and gastric histopathological lesions.
    Int J Cancer. 2020;147:3206-3214.
    PubMed     Abstract available

    November 2020
  8. LI B, Cheung KS, Wong IY, Leung WK, et al
    Calcium channel blockers are associated with lower gastric cancer risk: a territory-wide study with propensity score analysis.
    Int J Cancer. 2020 Nov 5. doi: 10.1002/ijc.33379.
    PubMed     Abstract available

  9. CANZIAN F, Rizzato C, Obazee O, Stein A, et al
    Genetic polymorphisms in the cag pathogenicity island of Helicobacter pylori and risk of stomach cancer and high-grade premalignant gastric lesions.
    Int J Cancer. 2020;147:2437-2445.
    PubMed     Abstract available

  10. LORENZEN S, Knorrenschild JR, Pauligk C, Hegewisch-Becker S, et al
    Phase III randomized, double-blind study of paclitaxel with and without everolimus in patients with advanced gastric or esophagogastric junction carcinoma who have progressed after therapy with a fluoropyrimidine/platinum-containing regimen (RADPAC).
    Int J Cancer. 2020;147:2493-2502.
    PubMed     Abstract available

  11. GARCIA RODRIGUEZ LA, Soriano-Gabarro M, Vora P, Cea Soriano L, et al
    Low-dose aspirin and risk of gastric and oesophageal cancer: A population-based study in the United Kingdom using The Health Improvement Network.
    Int J Cancer. 2020;147:2394-2404.
    PubMed     Abstract available

    October 2020
  12. LV K, Li R, Cao Y, Gu Y, et al
    LAG-3 expression associates with poor prognosis and immunoevasive contexture in EBV-positive and MLH1-defective gastric cancer patients.
    Int J Cancer. 2020 Oct 26. doi: 10.1002/ijc.33358.
    PubMed     Abstract available

    September 2020
  13. LADIGAN-BADURA S, Vangala DB, Engel C, Bucksch K, et al
    Value of upper GI endoscopy for gastric cancer surveillance in patients with Lynch syndrome.
    Int J Cancer. 2020 Sep 15. doi: 10.1002/ijc.33294.
    PubMed     Abstract available

    August 2020
  14. CARIOLI G, Bertuccio P, Malvezzi M, Rodriguez T, et al
    Cancer mortality predictions for 2019 in Latin America.
    Int J Cancer. 2020;147:619-632.
    PubMed     Abstract available

    June 2020
  15. FERRO A, Costa AR, Morais S, Bertuccio P, et al
    Fruits and vegetables intake and gastric cancer risk: a pooled analysis within the Stomach cancer Pooling (StoP) Project.
    Int J Cancer. 2020 Jun 11. doi: 10.1002/ijc.33134.
    PubMed     Abstract available

    May 2020
  16. HOLLECZEK B, Schottker B, Brenner H
    Helicobacter pylori infection, chronic atrophic gastritis and risk of stomach and esophagus cancer: Results from the prospective population-based ESTHER cohort study.
    Int J Cancer. 2020;146:2773-2783.
    PubMed     Abstract available

    March 2020
  17. SEO EH, Kim HJ, Kim JH, Lim B, et al
    ONECUT2 upregulation is associated with CpG hypomethylation at promoter-proximal DNA in gastric cancer and triggers ACSL5.
    Int J Cancer. 2020 Mar 4. doi: 10.1002/ijc.32946.
    PubMed     Abstract available

    December 2019
  18. BORNSCHEIN J, Wernisch L, Secrier M, Miremadi A, et al
    Transcriptomic profiling reveals three molecular phenotypes of adenocarcinoma at the gastroesophageal junction.
    Int J Cancer. 2019;145:3389-3401.
    PubMed     Abstract available

  19. HUANG SC, Ng KF, Yeh TS, Cheng CT, et al
    Subtraction of Epstein-Barr virus and microsatellite instability genotypes from the Lauren histotypes: Combined molecular and histologic subtyping with clinicopathological and prognostic significance validated in a cohort of 1,248 cases.
    Int J Cancer. 2019;145:3218-3230.
    PubMed     Abstract available

    November 2019
  20. JANG J, Wang T, Cai H, Ye F, et al
    The U-shaped association between body mass index and gastric cancer risk in the Helicobacter pylori Biomarker Cohort Consortium: a nested case-control study from eight East Asian cohort studies.
    Int J Cancer. 2019 Nov 19. doi: 10.1002/ijc.32790.

    October 2019
  21. UMEDA S, Kanda M, Miwa T, Tanaka H, et al
    Fraser extracellular matrix complex subunit 1 promotes liver metastasis of gastric cancer.
    Int J Cancer. 2019 Oct 9. doi: 10.1002/ijc.32705.
    PubMed     Abstract available

  22. FERRO A, Rosato V, Rota M, Costa AR, et al
    Meat intake and risk of gastric cancer in the Stomach cancer Pooling (StoP) Project.
    Int J Cancer. 2019 Oct 4. doi: 10.1002/ijc.32707.
    PubMed     Abstract available

    September 2019
  23. GIRAUD J, Molina-Castro S, Seeneevassen L, Sifre E, et al
    Verteporfin targeting YAP1/TAZ-TEAD transcriptional activity inhibits the tumorigenic properties of gastric cancer stem cells.
    Int J Cancer. 2019 Sep 6. doi: 10.1002/ijc.32667.
    PubMed     Abstract available

    August 2019
  24. SHAH SC, Dai Q, Zhu X, Peek RM Jr, et al
    Associations between calcium and magnesium intake and the risk of incident gastric cancer, a prospective cohort analysis of the NIH-AARP Diet and Health Study.
    Int J Cancer. 2019 Aug 31. doi: 10.1002/ijc.32659.
    PubMed     Abstract available

  25. SONG WM, Lin X, Liao X, Hu D, et al
    Multiscale Network Analysis Reveals Molecular Mechanisms and Key Regulators of the Tumor Microenvironment in Gastric Cancer.
    Int J Cancer. 2019 Aug 28. doi: 10.1002/ijc.32643.
    PubMed     Abstract available

  26. PIZZI MP, Bartelli TF, Pelosof AG, Freitas HC, et al
    Identification of DNA mutations in gastric washes from gastric adenocarcinoma patients: Possible implications for liquid biopsies and patient follow-up.
    Int J Cancer. 2019;145:1090-1098.
    PubMed     Abstract available

  27. HUANG C, Yuan W, Lai C, Zhong S, et al
    EphA2-to-YAP Pathway Drives Gastric Cancer Growth and Therapy Resistance.
    Int J Cancer. 2019 Aug 3. doi: 10.1002/ijc.32609.
    PubMed     Abstract available

    July 2019
  28. PRITCHETT NR, Maziarz M, Shu XO, Kamangar F, et al
    Serum ghrelin and esophageal and gastric cancer in two cohorts in China.
    Int J Cancer. 2019 Jul 27. doi: 10.1002/ijc.32597.
    PubMed     Abstract available

  29. DIJKSTERHUIS WPM, Verhoeven RHA, Slingerland M, Haj Mohammad N, et al
    Heterogeneity of first-line palliative systemic treatment in synchronous metastatic esophagogastric cancer patients: a real-world evidence study.
    Int J Cancer. 2019 Jul 24. doi: 10.1002/ijc.32580.
    PubMed     Abstract available

    June 2019
  30. QIU MZ, He CY, Lu SX, Guan WL, et al
    Prospective Observation: Clinical Utility of Plasma Epstein-Barr-Virus DNA Load in EBV-associated Gastric Carcinoma Patients.
    Int J Cancer. 2019 Jun 4. doi: 10.1002/ijc.32490.
    PubMed     Abstract available

    May 2019
  31. BOBROVNITCHAIA I, Valieris R, Drummond Couto Duarte R, Lima JP, et al
    APOBEC-mediated DNA alterations: a possible new mechanism of carcinogenesis in EBV-positive gastric cancer.
    Int J Cancer. 2019 May 15. doi: 10.1002/ijc.32411.
    PubMed     Abstract available

  32. SANIKINI H, Muller DC, Sophiea M, Rinaldi S, et al
    Anthropometric and reproductive factors and risk of esophageal and gastric cancer by subtype and subsite: results from the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort.
    Int J Cancer. 2019 May 3. doi: 10.1002/ijc.32386.
    PubMed     Abstract available

    April 2019
  33. CHEN Z, Liu Z, Zhang M, Huang W, et al
    EPHA2 blockade reverses acquired resistance to afatinib induced by EPHA2-mediated MAPK pathway activation in gastric cancer cells and avatar mice.
    Int J Cancer. 2019 Apr 7. doi: 10.1002/ijc.32313.
    PubMed     Abstract available

  34. HAAG GM, Czink E, Ahadova A, Schmidt T, et al
    Prognostic significance of microsatellite-instability in gastric and gastroesophageal junction cancer patients undergoing neoadjuvant chemotherapy.
    Int J Cancer. 2019;144:1697-1703.
    PubMed     Abstract available

    March 2019
  35. ROTA M, Alicandro G, Pelucchi C, Bonzi R, et al
    Education and gastric cancer risk - An individual participant data meta-analysis in the StoP project consortium.
    Int J Cancer. 2019 Mar 28. doi: 10.1002/ijc.32298.
    PubMed     Abstract available

  36. DIZDAR L, Werner TA, Drusenheimer JC, Mohlendick B, et al
    BRAF(V600E) mutation: A promising target in colorectal neuroendocrine carcinoma.
    Int J Cancer. 2019;144:1379-1390.
    PubMed     Abstract available

    February 2019
  37. CHO J, Ahn S, Son DS, Kim NK, et al
    Bridging Genomics and Phenomics of Gastric Carcinoma.
    Int J Cancer. 2019 Feb 23. doi: 10.1002/ijc.32228.
    PubMed     Abstract available

    January 2019
  38. KIM YB, Ahn JM, Bae WJ, Sung CO, et al
    Functional loss of ARID1A is tightly associated with high PD-L1 expression in gastric cancer.
    Int J Cancer. 2019 Jan 21. doi: 10.1002/ijc.32140.
    PubMed     Abstract available

  39. TAHARA S, Tahara T, Horiguchi N, Kato T, et al
    DNA methylation accumulation in gastric mucosa adjacent to cancer after Helicobacter pylori eradication.
    Int J Cancer. 2019;144:80-88.
    PubMed     Abstract available

    December 2018
  40. LIU YD, Yu L, Ying L, Balic J, et al
    Toll-like receptor 2 regulates metabolic reprogramming in gastric cancer via superoxide dismutase 2.
    Int J Cancer. 2018 Dec 11. doi: 10.1002/ijc.32060.
    PubMed     Abstract available

  41. BERTUCCIO P, Alicandro G, Rota M, Pelucchi C, et al
    Citrus fruit intake and gastric cancer: the Stomach cancer Pooling (StoP) project consortium.
    Int J Cancer. 2018 Dec 6. doi: 10.1002/ijc.32046.
    PubMed     Abstract available

  42. WANG S, Freedman ND, Loftfield E, Hua X, et al
    Alcohol consumption and risk of gastric cardia adenocarcinoma and gastric noncardia adenocarcinoma: A 16-year prospective analysis from the NIH-AARP diet and health cohort.
    Int J Cancer. 2018;143:2749-2757.
    PubMed     Abstract available

    November 2018
  43. ZHANG H, Zhu L, Bai M, Liu Y, et al
    Exosomal circRNA derived from gastric tumor promotes white adipose browning by targeting the miR-133/PRDM16 pathway.
    Int J Cancer. 2018 Nov 9. doi: 10.1002/ijc.31977.
    PubMed     Abstract available

    October 2018
  44. CHEN J, Guo H, Jiang H, Namusamba M, et al
    A BAP31 intrabody induces gastric cancer cell death by inhibiting p27(kip1) proteasome degradation.
    Int J Cancer. 2018 Oct 19. doi: 10.1002/ijc.31930.
    PubMed     Abstract available

  45. KATZ LH, Levi Z, Twig G, Kark JD, et al
    Risk factors associated with gastroenteropancreatic neuroendocrine tumors in a cohort of 2.3 million Israeli adolescents.
    Int J Cancer. 2018;143:1876-1883.
    PubMed     Abstract available

    September 2018
  46. MINAMI Y, Kanemura S, Oikawa T, Suzuki S, et al
    Associations of cigarette smoking and alcohol drinking with stomach cancer survival: A prospective patient cohort study in Japan.
    Int J Cancer. 2018;143:1072-1085.
    PubMed     Abstract available

    August 2018
  47. COMPANIONI O, Bonet C, Garcia N, Lazaro MJR, et al
    Genetic variation analysis in a follow-up study of gastric cancer precursor lesions confirms the association of MUC2 variants with the evolution of the lesions and identifies a significant association with NFKB1 and CD14.
    Int J Cancer. 2018 Aug 31. doi: 10.1002/ijc.31839.
    PubMed     Abstract available

  48. GYAWALI B, Kesselheim AS, D'Andrea E
    Does Helicobacter pylori eradication therapy to prevent gastric cancer increase all-cause mortality?
    Int J Cancer. 2018 Aug 28. doi: 10.1002/ijc.31772.
    PubMed     Abstract available

  49. MC MENAMIN UC, Kunzmann AT, Cook MB, Johnston BT, et al
    Hormonal and reproductive factors and risk of upper gastrointestinal cancers in men: A prospective cohort study within the UK Biobank.
    Int J Cancer. 2018;143:831-841.
    PubMed     Abstract available

  50. WOO HD, Fernandez-Jimenez N, Ghantous A, Degli Esposti D, et al
    Genome-wide profiling of normal gastric mucosa identifies Helicobacter pylori- and cancer-associated DNA methylome changes.
    Int J Cancer. 2018;143:597-609.
    PubMed     Abstract available

    July 2018
  51. CHENG L, Qiu L, Zhang R, Qian D, et al
    Functional variant of MTOR rs2536 and survival of Chinese gastric cancer patients.
    Int J Cancer. 2018 Jul 6. doi: 10.1002/ijc.31656.
    PubMed     Abstract available

  52. TAN J, Fu L, Chen H, Guan J, et al
    Association study of genetic variation in the autophagy lysosome pathway genes and risk of eight kinds of cancers.
    Int J Cancer. 2018;143:80-87.
    PubMed     Abstract available

    June 2018
  53. NDEGWA N, Ploner A, Liu Z, Roosaar A, et al
    Association between poor oral health and gastric cancer: A prospective cohort study.
    Int J Cancer. 2018 Jun 6. doi: 10.1002/ijc.31614.
    PubMed     Abstract available

    May 2018
  54. MIZUGUCHI A, Takai A, Shimizu T, Matsumoto T, et al
    Genetic features of multicentric/multifocal intramucosal gastric carcinoma.
    Int J Cancer. 2018 May 1. doi: 10.1002/ijc.31578.
    PubMed     Abstract available

    April 2018
  55. SHAO L, Li P, Ye J, Chen J, et al
    Risk of gastric cancer among patients with gastric intestinal metaplasia.
    Int J Cancer. 2018 Apr 29. doi: 10.1002/ijc.31571.
    PubMed     Abstract available

    March 2018
  56. KIYOZUMI Y, Iwatsuki M, Kurashige J, Ogata Y, et al
    PLOD2 as a potential regulator of peritoneal dissemination in gastric cancer.
    Int J Cancer. 2018 Mar 30. doi: 10.1002/ijc.31410.
    PubMed     Abstract available

  57. KIM H, Keum N, Giovannucci EL, Fuchs CS, et al
    Garlic intake and gastric cancer risk: results from two large prospective US cohort studies.
    Int J Cancer. 2018 Mar 23. doi: 10.1002/ijc.31396.
    PubMed     Abstract available

    February 2018
  58. TER VEER E, Creemers A, de Waal L, van Oijen MGH, et al
    Comparing cytotoxic backbones for first-line trastuzumab-containing regimens in HER2-positive advanced esophagogastric cancer: A meta-analysis.
    Int J Cancer. 2018 Feb 16. doi: 10.1002/ijc.31325.
    PubMed     Abstract available

  59. KIM HJ, Kang SK, Kwon WS, Kim TS, et al
    Forty-nine gastric cancer cell lines with integrative genomic profiling for development of c-MET inhibitor.
    Int J Cancer. 2018 Feb 13. doi: 10.1002/ijc.31304.
    PubMed     Abstract available

  60. HILL DG, Yu L, Gao H, Balic JJ, et al
    Hyperactive gp130/STAT3-driven gastric tumourigenesis promotes submucosal tertiary lymphoid structure development.
    Int J Cancer. 2018 Feb 8. doi: 10.1002/ijc.31298.
    PubMed     Abstract available

    January 2018
  61. ISHIKAWA T, Okayama T, Sakamoto N, Ideno M, et al
    Phase I clinical trial of adoptive transfer of expanded natural killer cells in combination with IgG1 antibody in patients with gastric or colorectal cancer.
    Int J Cancer. 2018 Jan 31. doi: 10.1002/ijc.31285.
    PubMed     Abstract available

    December 2017
  62. WANG W, Li Z, Wang J, Du M, et al
    A functional polymorphism in TFF1 promoter is associated with the risk and prognosis of gastric cancer.
    Int J Cancer. 2017 Dec 6. doi: 10.1002/ijc.31197.
    PubMed     Abstract available

    October 2017
  63. RHYU MG, Oh JH, Hong SJ
    Species-specific role of gene-adjacent retroelements in human and mouse gastric carcinogenesis.
    Int J Cancer. 2017 Oct 21. doi: 10.1002/ijc.31120.
    PubMed     Abstract available

  64. LUO G, Zhang Y, Guo P, Wang L, et al
    Global patterns and trends in stomach cancer incidence: Age, period and birth cohort analysis.
    Int J Cancer. 2017;141:1333-1344.
    PubMed     Abstract available

    July 2017
  65. LIU X, Zhang X, Zhang Z, Chang J, et al
    Plasma MicroRNA-based Signatures to Predict 3-year Postoperative Recurrence Risk for Stage II and III Gastric Cancer.
    Int J Cancer. 2017 Jul 19. doi: 10.1002/ijc.30895.
    PubMed     Abstract available

  66. ROTA M, Pelucchi C, Bertuccio P, Matsuo K, et al
    Alcohol consumption and gastric cancer risk - A pooled analysis within the StoP Project Consortium.
    Int J Cancer. 2017 Jul 18. doi: 10.1002/ijc.30891.
    PubMed     Abstract available

  67. TAKEGAWA N, Nonagase Y, Yonesaka K, Sakai K, et al
    DS-8201a, a new HER2-targeting antibody-drug conjugate incorporating a novel DNA topoisomerase I inhibitor, overcomes HER2-positive gastric cancer T-DM1 resistance.
    Int J Cancer. 2017 Jul 5. doi: 10.1002/ijc.30870.
    PubMed     Abstract available

  68. YU G, Hu N, Wang L, Wang C, et al
    Gastric microbiota features associated with cancer risk factors and clinical outcomes: A pilot study in gastric cardia cancer patients from Shanxi, China.
    Int J Cancer. 2017;141:45-51.
    PubMed     Abstract available

    June 2017
  69. KORSAK B, Almeida GM, Rocha S, Pereira C, et al
    Porphyrin Modified Trastuzumab Improves Efficacy of HER2 Targeted Photodynamic Therapy of Gastric Cancer.
    Int J Cancer. 2017 Jun 22. doi: 10.1002/ijc.30844.
    PubMed     Abstract available

    May 2017
  70. MIRANTI EH, Stolzenberg-Solomon R, Weinstein SJ, Selhub J, et al
    Low Vitamin B12 Increases Risk of Gastric Cancer: A Prospective Study of One-Carbon Metabolism Nutrients and Risk of Upper Gastrointestinal Tract Cancer.
    Int J Cancer. 2017 May 31. doi: 10.1002/ijc.30809.
    PubMed     Abstract available

  71. WANG X, Zhou Q, Yu Z, Wu X, et al
    Cancer-associated Fibroblast-derived Lumican Promotes Gastric Cancer Progression via the integrin beta1-FAK signaling pathway.
    Int J Cancer. 2017 May 23. doi: 10.1002/ijc.30801.
    PubMed     Abstract available

  72. JAKSZYN P, Fonseca-Nunes A, Lujan-Barroso L, Aranda N, et al
    Hepcidin levels and gastric cancer risk in the EPIC-EurGast Study.
    Int J Cancer. 2017 May 22. doi: 10.1002/ijc.30797.
    PubMed     Abstract available

    April 2017
  73. BUSBY J, Murchie P, Murray L, Iversen L, et al
    The effect of medications which cause inflammation of the gastro-oesophageal tract on cancer risk: a nested case-control study of routine Scottish data.
    Int J Cancer. 2017;140:1828-1835.
    PubMed     Abstract available

    February 2017
  74. RONCHETTI L, Melucci E, De Nicola F, Goeman F, et al
    DNA damage repair and survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy.
    Int J Cancer. 2017 Feb 24. doi: 10.1002/ijc.30668.
    PubMed     Abstract available

  75. MUHAMMAD JS, Nanjo S, Ando T, Yamashita S, et al
    Autophagy Impairment by Helicobacter pylori-induced Methylation Silencing of MAP1LC3Av1 Promotes Gastric Carcinogenesis.
    Int J Cancer. 2017 Feb 18. doi: 10.1002/ijc.30657.
    PubMed     Abstract available

    December 2016
  76. BRUSSELAERS N, Maret-Ouda J, Konings P, El-Serag HB, et al
    Menopausal hormone therapy and the risk of esophageal and gastric cancer.
    Int J Cancer. 2016 Dec 22. doi: 10.1002/ijc.30588.
    PubMed     Abstract available

  77. PIETRANTONIO F, Caporale M, Morano F, Scartozzi M, et al
    HER2 loss in HER2-positive gastric or gastroesophageal cancer after trastuzumab therapy: Implication for further clinical research.
    Int J Cancer. 2016;139:2859-2864.
    PubMed     Abstract available

    October 2016
  78. WANG T, Cai H, Sasazuki S, Tsugane S, et al
    Fruit and Vegetable Consumption, Helicobacter pylori Antibodies, and Gastric Cancer Risk: A Pooled Analysis of Prospective Studies in China, Japan and Korea.
    Int J Cancer. 2016 Oct 19. doi: 10.1002/ijc.30477.
    PubMed     Abstract available

  79. NAGASE H, Takeoka T, Urakawa S, Morimoto-Okazawa A, et al
    ICOS+ Foxp3+ TILs in gastric cancer are prognostic markers and effector regulatory T cells associated with Helicobacter pylori.
    Int J Cancer. 2016 Oct 18. doi: 10.1002/ijc.30475.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Gastric Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.